Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients
Clinical trial NCT01848925 · COMPLETED
Trial details
- NCT number
- NCT01848925
- Sponsor
- Prolong Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-07-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.